KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diebold Nixdorf (DBD) EPS (Weighted Average and Diluted) (2016 - 2025)

Diebold Nixdorf's EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $1.34 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 793.33% year-over-year to $1.34; the TTM value through Dec 2025 reached $2.56, up 681.82%, while the annual FY2025 figure was $2.54, 677.27% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $1.34 in Q4 2025 per DBD's latest filing, up from $1.11 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.34 in Q4 2025 to a low of -$8.46 in Q2 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.79, with a median of -$0.32 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 205.4% in 2022, then surged 793.33% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.62 in 2021, then tumbled by 205.4% to -$1.88 in 2022, then soared by 87.23% to -$0.24 in 2023, then surged by 162.5% to $0.15 in 2024, then skyrocketed by 793.33% to $1.34 in 2025.
  • Per Business Quant, the three most recent readings for DBD's EPS (Weighted Average and Diluted) are $1.34 (Q4 2025), $1.11 (Q3 2025), and $0.33 (Q2 2025).